HEPACORE LTD
6Patents
6Active
6Granted
47Portfolio score
Filing activity: Nov 13, 2003 → Feb 23, 2015 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7887831B2 | Bone enhancing composite | Human Necessities | 5 | Active |
| US9226949B2 | FGF-18 truncated variants having increased receptor specificity and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9610357B2 | Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof | Chemistry; Metallurgy | 1 | Active |
| US8298528B2 | Methods for bone regeneration using endothelial progenitor cell preparations | Chemistry; Metallurgy | 0 | Active |
| US9862753B2 | FGF-2 variants having N-terminal deletions and increased receptor selectivity and methods of use thereof | Human Necessities | 0 | Active |
| US8329870B2 | Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.